Modified-live virus for vaccination of healthy dairy or beef cattle as an aid in the prevention of disease caused by IBR, BVD Types 1&2, PI3 and BRSV, and as an aid in reduction of severity of pneumonic pasteurellosis caused by Mannheimia haemolytica. A DOI of 217 days has been demonstrated against respiratory disease caused by BVD Type 1b. Vaccination provides a protective effect against development of post-challenge viremia and leukopenia.
Also aids in the prevention of persistent BVD Types 1&2 infection of the fetal calf when used subcutaneously in the cow or heifer 30-60 days pre-breeding. May be used in pregnant cows or calves nursing pregnant cows provided cows were vaccinated pre-breeding, according to label instructions, with any Express FP vaccine, Pyramid 5, Pyramid 10 or Pyramid 5 + Presponse.
Dosage: 2 ml subcut. Protect animals from exposure for at least 14 days after vaccination. Calves vaccinated under 6 months of age should be revaccinated at 6 months. Healthy cattle should be vaccinated a minimum of 14 days prior to shipping or exposure to stress. Revaccinate annually. For Mannheimia haemolytica, booster dose with Presponse SQ is recommended whenever subsequent stress is likely. 21 day slaughter withdrawal.
Anaphylactoid reactions may occur. Antidote: Epinephrine.